Cell Line Development Serum Market Regional Outlook to 2031
The Cell Line Development Serum Market size was estimated to be US$ 1.16 billion in 2023 and is expected to reach US$ 2.00 billion by 2031; it is estimated to record a CAGR of 7.0% till 2031. Adoption of novel technologies for cell line development is likely to remain key Cell Line Development Serum Market trends.
Cell Line Development Serum Market Analysis
Advancements in drug development, government initiatives for vaccine development, increasing R&D activities in biotechnology and pharmaceutical companies, increasing demand for personalized medicine, and increasing demand for biopharmaceuticals is fuelling the growth of the viral antigen market. Increasing prevalence of chronic and infectious diseases globally requiring novel therapeutics is also driving the growth of the cell line development serum market
Cell Line Development Serum Market Overview
The cell line is a type of established cell culture, wherein the cells multiply in growing medium and in place which has space for growth. Different cell lines are made from other cells. The cell line development serum market growth is mainly attributed to the serum as a source of growth and adhesion factors, hormones, lipids, and minerals for cells' culture in basal media. The serum also regulates cell membrane permeability and serves as a carrier for enzymes, lipids, micronutrients, and trace elements into the cell. Quality and safety are critical considerations in the cell line development serum market, as the use of contaminated or low-quality serum can impact the cell culture performance and product quality.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Line Development Serum Market: Strategic Insights
Market Size Value in US$ 915.58 Million in 2019 Market Size Value by US$ 1,467.92 Million by 2027 Growth rate CAGR of 6.1% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Line Development Serum Market: Strategic Insights
| Market Size Value in | US$ 915.58 Million in 2019 |
| Market Size Value by | US$ 1,467.92 Million by 2027 |
| Growth rate | CAGR of 6.1% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Cell Line Development Serum Market Drivers and Opportunities
Increasing Vaccine Production
Increasing prevalence of chronic conditions as well as infectious diseases is leveraging the demand for vaccine production worldwide. As cell line development plays a crucial role in vaccine development and process of drug discovery, the market is estimated to witness significant growth during the forecast period. Major pharmaceutical and biotechnology players are currently focusing on the establishment of an advanced research facilities to boost the process of vaccine development. Increasing use of cell line for effect of vaccine is fuelling the demand for cell line development which in turn fuels the growth of the cell line development serum market.
Increasing Awareness about Regenerative Medicine – An Opportunity of Cell Line Development Serum Market
Over the last few years, the tissue engineering industry has emerged notably, and it has evolved into the broader spectrum of regenerative medicine. Regenerative medicine focuses on the development of clinical therapies for the repair, maintenance, replacement, and enhancement of biological function, with the use of cell engineering. Cell line development is a crucial and invariable part of regenerative medicine. The stem cells play a crucial role in regenerative medicine research revolves around the use of various types of stem cells such as adult, embryonic, induced pluripotent cells. Cell lines are used in testing and development of drugs, cell-based therapy, and research related to cancer tissues. New regenerative medicine developed in pharmaceutical companies are safely and effectively tested on stem cells to check the potential of the drugs developed and their level of toxicity. Thus, advancements in the regenerative medicine is anticipated to boost the demand for serum used in cell line development.
Cell Line Development Serum Market Report Segmentation Analysis
Key segments that contributed to the derivation of the Cell Line Development Serum Market analysis are type and application.
- Based on type, the Cell Line Development Serum Market is segmented fetal bovine serum, adult bovine serum, porcine serum, horse serum, and others. The fetal bovine serum segment held the largest market share in 2023.
- By application, the market is segmented into bioproduction, drug discovery, tissue engineering and regenerative medicine, toxicity testing, and academic research. The bioproduction segment held the largest share of the market in 2023.
Cell Line Development Serum Market Share Analysis by Geography
The geographic scope of the Cell Line Development Serum Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the Cell Line Development Serum Market. In North America, the US holds the significant share of the cell line development serum market. The growth in North America is characterized by an increase in the production for innovative products from pharmaceutical and biotechnology companies, the presence of key market players in the region, and extensive R&D conducted by academic and research institutes. Moreover, increasing focus on advanced method incorporation in development of precision medicine and massive funds from government and other organizations for genomic research has further stimulated the growth of the cell line development serum market in North America.
Cell Line Development Serum Market Report Scope
Cell Line Development Serum Market News and Recent Developments
The Cell Line Development Serum Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for viral antigens and strategies:
- BioIVT launched human AB serum product line to supplement cell culture media and facilitate cell and gene therapy development. BioIVT is offering both plasma-derived and off-the-clot serum collected from healthy, male AB blood type donors. All products are sterile, filtered, and ready for cell culture. (Source: BioIVT, Company Website, 2021)
- In Feb 2024, Gemini Bioproducts LLC launched a new human AB serum product, GemCellTM Plus Xeno Free, for the cell therapy and regenerative medicine markets. (Source: Biospace, Press Release, 2024)
Cell Line Development Serum Market Report Coverage and Deliverables
The “Cell Line Development Serum Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; By Application ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
- Thermo Fisher Scientific Inc.
- MERCK KGaA
- Cytiva (Danaher)
- GE Healthcare
- Lonza Group
- HiMedia Laboratories
- Sartorius
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- American Type Culture Collection (ATCC)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For